{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:30:05Z","timestamp":1786624205991,"version":"build-2736575974"},"reference-count":22,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Addictive Diseases"],"DOI":"10.1080\/10550887.2026.2692669","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:42:41Z","timestamp":1786621361000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive oral naltrexone for breakthrough craving in patients receiving extended-release injectable naltrexone for alcohol use disorder: Three cases"],"prefix":"10.1080","author":[{"given":"Gabriel","family":"Felipe Tosta","sequence":"first","affiliation":[{"name":"Universidade de Santa Cruz do Sul","place":["Santa Cruz do Sul, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-7016","authenticated-orcid":false,"given":"Ruan Pablo","family":"Duarte Freitas","sequence":"additional","affiliation":[{"name":"Faculdade Zarns","place":["Salvador, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alamir","sequence":"additional","affiliation":[{"name":"Ohio University Heritage College of Osteopathic Medicine","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajitpaul","family":"Basra","sequence":"additional","affiliation":[{"name":"Psychiatry and Psychology Department, Cleveland Clinic","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Salzman","sequence":"additional","affiliation":[{"name":"Psychiatry Department, University Hospitals Cleveland Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Harp","sequence":"additional","affiliation":[{"name":"Psychiatry and Psychology Department, Cleveland Clinic","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8963-5701","authenticated-orcid":false,"given":"Brian S.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Psychiatry and Psychology Department, Cleveland Clinic","place":["Cleveland, USA"]},{"name":"Psychiatry Department, University Hospitals Cleveland Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-2690","authenticated-orcid":false,"given":"Akhil","family":"Anand","sequence":"additional","affiliation":[{"name":"Psychiatry and Psychology Department, Cleveland Clinic","place":["Cleveland, USA"]},{"name":"Psychiatry Department, University Hospitals Cleveland Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1240"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-6-17"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agx088"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2023.0307"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220821"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agw038"},{"key":"e_1_3_4_8_1","unstructured":"Duramed Pharmaceuticals Inc 2013. Revia (naltrexone hydrochloride tablets USP) 50\u2009mg: prescribing information [Package insert]. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018932s017lbl."},{"key":"e_1_3_4_9_1","unstructured":"Alkermes Inc. 2010. Vivitrol (naltrexone for extended-release injectable suspension): prescribing information [Package insert]. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021897s015lbl."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.04.006"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666130-00006"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100919"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.10.1214"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2007.68.862"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00052.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16946-4"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03259-8"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318100-000000000-00000"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2742"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12934"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874941001003010076"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716632512"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109481"}],"container-title":["Journal of Addictive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10550887.2026.2692669","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10550887.2026.2692669","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10550887.2026.2692669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:42:43Z","timestamp":1786621363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10550887.2026.2692669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":22,"alternative-id":["10.1080\/10550887.2026.2692669"],"URL":"https:\/\/doi.org\/10.1080\/10550887.2026.2692669","relation":{},"ISSN":["1055-0887","1545-0848"],"issn-type":[{"value":"1055-0887","type":"print"},{"value":"1545-0848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjad20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}